By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


Company News
Regen BioPharma Files Application To Trade Publicly On OTCQB 5/24/2016 10:22:14 AM
Regen BioPharma Announces ucVax: Universal Donor Cancer Cellular Immunotherapy 5/19/2016 11:18:09 AM
Regen BioPharma Discusses Recent Developments In Aplastic Anemia Therapy And Future Potential Expansion Of HemaXellerate 5/11/2016 8:30:54 AM
Regen BioPharma Receives Preliminary Clinical Data From Pan Am Cancer Center Regarding Their HemaXellerate Study In Cancer Patients 5/3/2016 7:26:32 AM
Regen BioPharma 's HemaXellerate Therapy For Treating Aplastic Anemia Licensed For Proof Of Concept Study 4/28/2016 6:18:18 AM
Regen BioPharma Series A Preferred Stock Begins Trading Under The Symbol RGBPP On The OTC PINK 4/21/2016 6:31:40 AM
Regen BioPharma Submits IND Application To FDA On tCellVax, A Checkpoint Inhibitor For Cancer Therapy 3/23/2016 6:46:59 AM
Regen BioPharma Completes Preclinical Experimentation For Its siRNA NR2F6 Checkpoint Inhibitor 2/24/2016 6:55:27 AM
Regen BioPharma 's Immune Checkpoint Inhibitor Found To Stimulate Key Immune System Proteins Interleukin-17 And Interleukin-18 2/17/2016 6:52:19 AM
Regen BioPharma Files Patent Application Covering Innate Immune Activating NR2F6 Silenced CAR-T Cell For Solid Tumors 2/3/2016 6:51:20 AM